# LifeMD, Inc. (LFMD)

> Source: Nexqual · https://nexqual.com/LFMD · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, LifeMD, Inc. (LFMD), nexqual.com/LFMD" · informational, not investment advice.

**Price:** USD 2.46 (+3.80% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.37 · day 2.34–2.5 · 52w 2.34–6.44 · market cap $119M · NGM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (8 analysts), mean target USD 8.13 (range 5–15).
- Total return with dividends: 1Y -61.7% vs S&P 500 +18.1%; 5Y -52.5% vs S&P 500 +85.1%.
- Next earnings: 2026-11-09, EPS estimate USD -0.01, revenue estimate $48.9M.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 8 analysts; mean target USD 8.13 (low 5, high 15).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-17 | HC Wainwright & Co. | Reiterated | Buy | $9 |
| 2026-08-07 | HC Wainwright & Co. | Target lowered | Buy | $10 → $9 |
| 2026-08-06 | B. Riley Securities | Target lowered | Buy | $10 → $8 |
| 2026-08-06 | BTIG | Target lowered | Buy | $10 → $9 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -61.7% | -52.5% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -61.9% | -13.8% |
| Volatility (annualized) | 78.3% | 79.9% |
| Max drawdown | -63.1% (Oct 2025→Oct 2026) | -83.3% (Jun 2025→Oct 2026) |

## Peers (Health Information Services)
CARL (Carlsmed, Inc.) USD 13.95 -3.59% · CTEV (Claritev Corporation) USD 23.86 +0.59% · NRC (NRC Health) USD 21.11 +4.66% · EVH (Evolent Health, Inc) USD 4.87 +5.87% · WEAV (Weave Communications, Inc.) USD 7.39 +0.27% · SOPH (SOPHiA GENETICS SA) USD 7.29 +2.82%

## More
Full page: https://nexqual.com/LFMD · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt